Passa al contenuto
Merck
Tutte le immagini(1)

Key Documents

View All Documentation

53467

Sigma-Aldrich

2,3-Dioleyloxy-1-(dimethylamino)propane

≥98.0% (TLC)

Sinonimo/i:

1,2-Dioleyloxy-3-(dimethylamino)propane, N,N-Dimethyl-2,3-bis[(9Z)-9-octadecen-1-yloxy]-1-propanamine, DODMA

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C41H81NO2
Numero CAS:
104162-47-2
Peso molecolare:
620.09
Beilstein:
10139013
Numero MDL:
MFCD22200991
Codice UNSPSC:
12352211
ID PubChem:
329757947
NACRES:
NA.85

Origine biologica

synthetic

Saggio

≥98.0% (TLC)

Forma fisica

liquid

Gruppo funzionale

amine
ether

Tipo di lipide

cationic lipids

Temperatura di conservazione

−20°C

Stringa SMILE

CCCCCCCC\C=C/CCCCCCCCOCC(CN(C)C)OCCCCCCCC\C=C/CCCCCCCC

InChI

1S/C41H81NO2/c1-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-43-40-41(39-42(3)4)44-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-2/h19-22,41H,5-18,23-40H2,1-4H3/b21-19-,22-20-
GLGLUQVVDHRLQK-WRBBJXAJSA-N

Categorie correlate

Confezionamento

Bottomless glass bottle. Contents are inside inserted fused cone.

Codice della classe di stoccaggio

10 - Combustible liquids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 8

1 of 8

GL67 Avanti Research™ - A Croda Brand

Avanti

890893P

GL67

DMG-PEG 2000 Avanti Research™ - A Croda Brand

Avanti

880151P

DMG-PEG 2000

18:1 TAP (DOTAP) Avanti Research™ - A Croda Brand

Avanti

890890P

18:1 TAP (DOTAP)

1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine ≥99.0% (10 mg phospholipid per ml CHCl3, TLC)

Sigma-Aldrich

42490

1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine

18:0 PC (DSPC) Avanti Research™ - A Croda Brand

Avanti

850365P

18:0 PC (DSPC)

1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine ≥97.0% (TLC)

Sigma-Aldrich

76548

1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine

DOTAP Liposomal Transfection Reagent >99% (TLC), liquid, suitable for transfection

Roche

11202375001

DOTAP Liposomal Transfection Reagent

Colesterolo Sigma Grade, ≥99%

Sigma-Aldrich

C8667

Colesterolo

Lloyd B Jeffs et al.
Pharmaceutical research, 22(3), 362-372 (2005-04-20)
A fully scalable and extrusion-free method was developed to prepare rapidly and reproducibly stabilized plasmid lipid particles (SPLP) for nonviral, systemic gene therapy. Liposomes encapsulating plasmid DNA were formed instantaneously by mixing lipids dissolved in ethanol with an aqueous solution
Yujing Li et al.
Nanomedicine : nanotechnology, biology, and medicine, 13(2), 371-381 (2016-10-18)
Microfluidic systems can accelerate clinical translation of nanoparticles due to their ability to generate nanoparticles in a well-controlled and reproducible manner. In this study, a single-step process based on microfluidic focusing (MF) was employed to synthesize transferrin-conjugated lipid nanoparticles (Tf-LNPs)
Adam Judge et al.
Molecular therapy : the journal of the American Society of Gene Therapy, 13(2), 328-337 (2005-11-09)
The systemic application of nucleic acid drugs requires delivery systems that overcome the poor pharmacokinetics, limited biodistribution, and inefficient uptake of nucleic acids. PEGylated liposomes show considerable promise because of their intrinsic ability to accumulate at disease sites and facilitate
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids.
Heyes, J., et al.
J. Controlled Release, 107, 276-287 (2005)
Xi Wang et al.
Molecules (Basel, Switzerland), 24(19) (2019-10-03)
Glioma is one of the most aggressive and common malignant brain tumors. Due to the presence of the blood-brain barrier (BBB), the effectiveness of therapeutics is greatly affected. In this work, to develop an efficient anti-glioma drug with targeting and
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.